Doutor Nichires Holdings Co., Ltd.

As of August 31, 2024, Doutor Nichires Holdings Co., Ltd. carries a market capitalization of 96.98B, placing it among publicly traded companies globally. Its enterprise value stands at 62.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Doutor Nichires Holdings Co., Ltd.'s next confirmed earnings release is scheduled for January 8, 2027.

As of August 31, 2024, Doutor Nichires Holdings Co., Ltd. has 43.84M shares outstanding.

As of August 31, 2024, Doutor Nichires Holdings Co., Ltd. trades at a trailing price-to-earnings ratio of 15.96. The price-to-sales ratio is 0.67, and the price-to-book ratio stands at 0.95.

As of August 31, 2024, Doutor Nichires Holdings Co., Ltd. trades at an EV/EBITDA multiple of 6.99 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.99 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 62.81B versus a market cap of 96.98B, with the gap driven by net debt and cash on the balance sheet.

As of August 31, 2024, Doutor Nichires Holdings Co., Ltd. maintains a current ratio of 2.74, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.26, indicating elevated leverage, while an interest coverage ratio of 449.45 demonstrates strong ability to service its debt obligations.

Over the twelve months ended August 31, 2024, Doutor Nichires Holdings Co., Ltd. posted a return on equity (ROE) of 6.05, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.09 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.69, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.89, useful for judging operating efficiency across full business cycles. The company generates approximately 52.41M in revenue per employee across its workforce of 2,765.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 10.74 indicates how many times Doutor Nichires Holdings Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended August 31, 2024, Doutor Nichires Holdings Co., Ltd. recorded 2.52B in income tax expense. That works out to an effective tax rate of 29.17, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 8.64B, leaving 6.07B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Doutor Nichires Holdings Co., Ltd.'s stock has gained approximately 42.63% over the past 52 weeks. The 50-day moving average sits at 3,269.90, while the 200-day moving average is 2,948.05.

Over the twelve months ended August 31, 2024, Doutor Nichires Holdings Co., Ltd. generated 144.93B in revenue and converted that into 6.07B in net income, yielding earnings per share of 139.58. EBITDA reached 8.99B, while operating income came in at 8.99B.

As of August 31, 2024, Doutor Nichires Holdings Co., Ltd. holds 36.82B in cash and equivalents against 2.32B in total debt, resulting in a net debt position of -36.08B. Total book value stands at 102.43B, with working capital of 37.76B providing operational flexibility.

Over the twelve months ended August 31, 2024, Doutor Nichires Holdings Co., Ltd. posted a gross margin of 60.33, reflecting its pricing power and cost economics. The operating margin of 6.21 and net profit margin of 4.19 provide insight into operational efficiency.

As of August 31, 2024, Doutor Nichires Holdings Co., Ltd. has an Altman Z-Score of 4.51, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.